Shareholders meeting

September 07, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349 Reg.: Annual Report for the Financial Year 2025-26 including Notice of the 42nd Annual General Meeting and details of Cut-off date for remote E-voting and E-voting Period Dear Sir / Madam, This is in continuation to our letter dated August 13, 2026, intimating that the 42nd Annual General Meeting (“AGM”) of the Company will be held on Tuesday, September 29, 2026, at 11:30 A.M. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) in compliance with the applicable General Circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Pursuant to the provisions of Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), please find enclosed the Notice of 42nd AGM and the Annual Report for the financial year 2025-26, which is being sent to the Members through electronic mode. The same are also attached and made available on the website of the Company at www.panaceabiotec.com. Further, pursuant to SEBI LODR Regulations, a letter containing the web-link of the AGM Notice and Annual Report for the financial year 2025-26 is being sent at the registered address of the shareholders whose e-mail addresses are not registered with the Company / RTA / Depository Participant(s). Also pursuant to the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended from time to time and Regulation 44 of the SEBI LODR Regulations, the Company is pleased to provide remote e-voting facility to its members to cast their votes electronically on all resolutions set forth in the enclosed AGM Notice. Further, relating to the AGM of the Company, you are requested to take note of the following: 1. The cut-off date for the purpose of exercising remote e-voting, shall be Tuesday, September 22, 2026. 2. The remote e-voting period shall commence on Saturday, September 26, 2026 (from 09:00 a.m. IST) and end on Monday, September 28, 2026 (upto 05:00 p.m. IST). 3. The remote e-Voting facility will also be available at the AGM for the members attending the AGM. This is for your kind information and record please. Thanking you, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager - Legal & Company Secretary Encl.: As Above Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office: Ambala - Chandigarh Highway, Lalru - 140501, Punjab, India Corp. Office: B-1 Extn./A-27, Mohan Co-operative Industrial Estate, Mathura Road, New Delhi - 110044 Website: www.panaceabiotec.com, E-mail: companysec@panaceabiotec.com, Tel: +91 11 41679000 NOTICE NOTICE is hereby given that the 42nd Annual General Meeting (“AGM”) of the Members of Panacea Biotec Limited (“the Company”) will be held on Tuesday, September 29, 2026, at 11:30 A.M. through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”), to transact the following businesses: ORDINARY BUSINESS: 1. To consider and adopt (a) the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors thereon; and (b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, including Auditors’ Report thereon and in this regard, if thought fit, to pass the following resolutions as Ordinary Resolutions: a) “RESOLVED THAT the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Directors and the Auditors thereon, as circulated to the Members, be and are hereby considered and adopted.” b) “RESOLVED THAT the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Auditors’ Report thereon, as circulated to the Members, be and are hereby considered and adopted.” 2. To appoint a director in place of Mr. Ankesh Jain who retires by rotation and being eligible, offers himself for re-appointment and in this regard, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 of the Companies Act, 2013, Mr. Ankesh Jain (DIN: 03556647) who retires by rotation at this meeting and being eligible, offered himself for re-appointment, be and is hereby re-appointed as a director, liable to retire by rotation.” 3. To appoint a director in place of Mr. Harshet Jain who retires by rotation and being eligible, offers himself for re-appointment and in this regard, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 of the Companies Act, 2013, Mr. Harshet Jain (DIN: 08732974) who retires by rotation at this meeting and being eligible, offered himself for re-appointment, be and is hereby re-appointed as a director, liable to retire by rotation.” SPECIAL BUSINESS: 4. To consider appointment of Mr. Rajinder Singh Manku (DIN: 09706881) as an independent director of the Company and in this regard, if thought fit, to pass with or without modification(s), the following resolution, as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152, 161 and other applicable provisions of the Companies Act, 2013 (“the Act”) read with the Companies (Appointment and Qualification of Directors) Rules, 2014, Schedule IV to the Act and the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) (including any statutory modification(s) or re-enactment(s) thereof for the time being in force) and the Articles of Association of the Company, Mr. Rajinder Singh Manku (DIN: 09706881), who was appointed by the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee as an additional director (in the category of non-executive independent director) of the Company and who meets the applicable criteria for independence under the Act and the SEBI LODR Regulations and in respect of whom the Company has received a notice in writing from a Member under Section 160(1) of the Act, be and is hereby appointed as an independent director of the Company, not liable to retire by rotation, for a period of 5 (five) consecutive years with effect from July 01, 2026. RESOLVED FURTHER THAT the Board of Directors, the Company Secretary and the Chief Financial Officer of the Company be and are hereby severally authorised to do all such acts, matters, deeds and things and to sign all such documents, papers and writings as may be necessary or expedient to give effect to this resolution and for matters connected therewith or incidental thereto.” 5. To consider and ratify the remuneration of Cost Auditors and in this regard, if thought fit, to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 148 and other applicable provisions, if any, of the Companies Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), the remuneration of ₹1,25,000/- (Rupees One Lakh Twenty Five Thousand Only) (in [Showing first 8,000 characters — download PDF for full document]